Arbutus Biopharma
ABUS
#6260
Rank
S$0.83 B
Marketcap
$4.35
Share price
-7.98%
Change (1 day)
7.43%
Change (1 year)

Earnings for Arbutus Biopharma (ABUS)

Earnings in 2024 (TTM): -S$93.26 Million

According to Arbutus Biopharma 's latest financial reports the company's current earnings are S$6.17 Million. , an increase over its 2023 earnings that were of -S$98.02 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Arbutus Biopharma from 2008 to 2024

Annual earnings

Year Earnings Change
2024 -S$94.08 Million-4.02%
2023 -S$98.02 Million12.05%
2022 -S$87.48 Million-14.74%
2021 -S$0.11 Billion19.61%
2020 -S$85.77 Million-61.69%
2019 -S$0.23 Billion171.23%
2018 -S$82.54 Million-43.58%
2017 -S$0.15 Billion-77.77%
2016 -S$0.66 Billion532.77%
2015 -S$0.11 Billion99.05%
2014 -S$52.26 Million175.82%
2013 -S$18.95 Million-143.7%
2012 S$43.35 M-399.11%
2011 -S$14.5 Million-39.03%
2010 -S$23.78 Million100.55%
2009 -S$11.86 Million-28.56%
2008 -S$16.6 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
S$47.47 M-150.46%๐Ÿ‡บ๐Ÿ‡ธ USA
-S$2.91 Million-96.91% Bahamas